Phase III, Random, Blind to Observer, Multicenter, Comparative Study, to Demonstrate Absence of Inferiority in Safety and Efficacy of Topical Ointment SB-275833 at 1% Applied Twice a Day for Five Days, Against Topical Ointment of 2% Sodium Fusidate Applied Three Times a Day for 7 Days in the Treatment of Adult and Pediatric Subjects with Impetigo

计划入组 0 人

Multicenter, Double Blind, Randomized, Parallel Groups, Controlled with Vehicle Study to Determine the Clinical Bioequivalence of a 2% Mupirocin Topical Ointment and Bactroban Ointment in Subjects with Impetigo

计划入组 0 人

A Trial to Assess Safety, Tolerability, and Pharmacokinetics of AN01 Inhalation Powder in Healthy Participants

计划入组 25 人 · 首次发布于 2026 年 4 月 28 日

IN01

N01

RP-L101

HIV Vaccine Breakthrough: New Candidate Successfully Generates Broadly Neutralizing Antibodies